JP4324669B2 - 環状ウレタンの製造方法 - Google Patents
環状ウレタンの製造方法 Download PDFInfo
- Publication number
- JP4324669B2 JP4324669B2 JP2004013692A JP2004013692A JP4324669B2 JP 4324669 B2 JP4324669 B2 JP 4324669B2 JP 2004013692 A JP2004013692 A JP 2004013692A JP 2004013692 A JP2004013692 A JP 2004013692A JP 4324669 B2 JP4324669 B2 JP 4324669B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- azetidine
- aziridine
- reaction
- carbon dioxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 title claims description 30
- 125000004122 cyclic group Chemical group 0.000 title claims description 25
- 238000004519 manufacturing process Methods 0.000 title claims description 19
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 80
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 40
- 239000001569 carbon dioxide Substances 0.000 claims description 40
- 238000006243 chemical reaction Methods 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 35
- -1 cyclic amine Chemical class 0.000 claims description 29
- 239000002904 solvent Substances 0.000 claims description 23
- 239000012429 reaction media Substances 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 11
- 125000003342 alkenyl group Chemical group 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 125000000304 alkynyl group Chemical group 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 150000002367 halogens Chemical group 0.000 claims description 10
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 claims description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 7
- 229910052740 iodine Inorganic materials 0.000 claims description 7
- 239000011630 iodine Substances 0.000 claims description 7
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- IADUEWIQBXOCDZ-UHFFFAOYSA-N azetidine-2-carboxylic acid Chemical compound OC(=O)C1CCN1 IADUEWIQBXOCDZ-UHFFFAOYSA-N 0.000 claims description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 5
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 4
- IADUEWIQBXOCDZ-VKHMYHEASA-N Azetidine-2-carboxylic acid Natural products OC(=O)[C@@H]1CCN1 IADUEWIQBXOCDZ-VKHMYHEASA-N 0.000 claims description 3
- 229910020366 ClO 4 Inorganic materials 0.000 claims description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 claims description 3
- VKCBXONEZGIOSP-UHFFFAOYSA-N 1-(4-methylphenyl)sulfonylazetidine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CCC1 VKCBXONEZGIOSP-UHFFFAOYSA-N 0.000 claims description 2
- VBNWSEVVMYMVLC-UHFFFAOYSA-N 1-(4-methylphenyl)sulfonylaziridine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC1 VBNWSEVVMYMVLC-UHFFFAOYSA-N 0.000 claims description 2
- SXDHZDWQVSISGO-UHFFFAOYSA-N 2-(2-nitrophenyl)azetidine Chemical compound [O-][N+](=O)C1=CC=CC=C1C1NCC1 SXDHZDWQVSISGO-UHFFFAOYSA-N 0.000 claims description 2
- PSSWSJTYURMJHL-UHFFFAOYSA-N 2-(2-nitrophenyl)aziridine Chemical compound [O-][N+](=O)C1=CC=CC=C1C1NC1 PSSWSJTYURMJHL-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- BLLPFMQOLSYTBX-UHFFFAOYSA-N azetidine-2,3-dicarboxylic acid Chemical compound OC(=O)C1CNC1C(O)=O BLLPFMQOLSYTBX-UHFFFAOYSA-N 0.000 claims description 2
- WBGBOXYJYPVLQJ-UHFFFAOYSA-N aziridine-2-carboxylic acid Chemical compound OC(=O)C1CN1 WBGBOXYJYPVLQJ-UHFFFAOYSA-N 0.000 claims description 2
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 claims description 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 2
- 125000004069 aziridinyl group Chemical group 0.000 claims 1
- 230000035484 reaction time Effects 0.000 description 14
- 239000000126 substance Substances 0.000 description 12
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 5
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 150000001541 aziridines Chemical class 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000003495 polar organic solvent Substances 0.000 description 3
- AZHWVHNIAGJINK-UHFFFAOYSA-N 1-benzhydrylazetidine Chemical compound C1CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 AZHWVHNIAGJINK-UHFFFAOYSA-N 0.000 description 2
- VYONOYYDEFODAJ-UHFFFAOYSA-N 2-(1-Aziridinyl)ethanol Chemical compound OCCN1CC1 VYONOYYDEFODAJ-UHFFFAOYSA-N 0.000 description 2
- OZDGMOYKSFPLSE-UHFFFAOYSA-N 2-Methylaziridine Chemical compound CC1CN1 OZDGMOYKSFPLSE-UHFFFAOYSA-N 0.000 description 2
- ARILQDNHZGKJBK-UHFFFAOYSA-N 5-phenyl-1,3-oxazolidin-2-one Chemical compound O1C(=O)NCC1C1=CC=CC=C1 ARILQDNHZGKJBK-UHFFFAOYSA-N 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 2
- 150000001539 azetidines Chemical class 0.000 description 2
- QXNDZONIWRINJR-UHFFFAOYSA-N azocane Chemical compound C1CCCNCCC1 QXNDZONIWRINJR-UHFFFAOYSA-N 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000004714 phosphonium salts Chemical class 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- ZXMGHDIOOHOAAE-UHFFFAOYSA-N 1,1,1-trifluoro-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)NS(=O)(=O)C(F)(F)F ZXMGHDIOOHOAAE-UHFFFAOYSA-N 0.000 description 1
- QSHMWSLFNQLCNI-UHFFFAOYSA-N 1-(2-phenylethyl)aziridine Chemical compound C1CN1CCC1=CC=CC=C1 QSHMWSLFNQLCNI-UHFFFAOYSA-N 0.000 description 1
- CASDNPHWJOQUQX-UHFFFAOYSA-N 1-benzylaziridine Chemical compound C=1C=CC=CC=1CN1CC1 CASDNPHWJOQUQX-UHFFFAOYSA-N 0.000 description 1
- XIEJPTDTTYFCJM-UHFFFAOYSA-N 1-butylaziridine Chemical compound CCCCN1CC1 XIEJPTDTTYFCJM-UHFFFAOYSA-N 0.000 description 1
- ZEZOIRFVLXEXBC-UHFFFAOYSA-N 1-ethylazetidine Chemical compound CCN1CCC1 ZEZOIRFVLXEXBC-UHFFFAOYSA-N 0.000 description 1
- UJGVUACWGCQEAO-UHFFFAOYSA-N 1-ethylaziridine Chemical compound CCN1CC1 UJGVUACWGCQEAO-UHFFFAOYSA-N 0.000 description 1
- WWYVZTLIFYLZFM-UHFFFAOYSA-N 1-methylazetidine Chemical compound CN1CCC1 WWYVZTLIFYLZFM-UHFFFAOYSA-N 0.000 description 1
- XLJQPXVBQNJNLW-UHFFFAOYSA-N 1-methylaziridine Chemical group CN1CC1 XLJQPXVBQNJNLW-UHFFFAOYSA-N 0.000 description 1
- MCTWTZJPVLRJOU-UHFFFAOYSA-O 1-methylimidazole Chemical class CN1C=C[NH+]=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-O 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- JNWYXXQAOGBPNL-UHFFFAOYSA-N 1-phenylazetidine Chemical compound C1CCN1C1=CC=CC=C1 JNWYXXQAOGBPNL-UHFFFAOYSA-N 0.000 description 1
- YKNKBBMRKMLLJS-UHFFFAOYSA-N 1-phenylaziridine Chemical compound C1CN1C1=CC=CC=C1 YKNKBBMRKMLLJS-UHFFFAOYSA-N 0.000 description 1
- APKJRCRGAMSYHH-UHFFFAOYSA-N 1-propylaziridine Chemical compound CCCN1CC1 APKJRCRGAMSYHH-UHFFFAOYSA-N 0.000 description 1
- BMVHDBKYVGUEIX-UHFFFAOYSA-N 2,3-dimethylazetidine Chemical compound CC1CNC1C BMVHDBKYVGUEIX-UHFFFAOYSA-N 0.000 description 1
- NYSDJELAGVMAKI-UHFFFAOYSA-N 2,3-diphenylazetidine Chemical compound C1NC(C=2C=CC=CC=2)C1C1=CC=CC=C1 NYSDJELAGVMAKI-UHFFFAOYSA-N 0.000 description 1
- OIVRMEOAUMQHAQ-UHFFFAOYSA-N 2,3-diphenylaziridine Chemical compound N1C(C=2C=CC=CC=2)C1C1=CC=CC=C1 OIVRMEOAUMQHAQ-UHFFFAOYSA-N 0.000 description 1
- CSWPOLMVXVBCSV-UHFFFAOYSA-N 2-ethylaziridine Chemical compound CCC1CN1 CSWPOLMVXVBCSV-UHFFFAOYSA-N 0.000 description 1
- DLBWPRNUXWYLRN-UHFFFAOYSA-N 2-methylazetidine Chemical compound CC1CCN1 DLBWPRNUXWYLRN-UHFFFAOYSA-N 0.000 description 1
- CLNGGMJEJSANIE-UHFFFAOYSA-N 2-phenylazetidine Chemical compound N1CCC1C1=CC=CC=C1 CLNGGMJEJSANIE-UHFFFAOYSA-N 0.000 description 1
- GBIKLFWSUVVUKT-UHFFFAOYSA-N 2-phenylaziridine Chemical compound C1NC1C1=CC=CC=C1 GBIKLFWSUVVUKT-UHFFFAOYSA-N 0.000 description 1
- VWIIJDNADIEEDB-UHFFFAOYSA-N 3-methyl-1,3-oxazolidin-2-one Chemical compound CN1CCOC1=O VWIIJDNADIEEDB-UHFFFAOYSA-N 0.000 description 1
- NCTCGHLIHJJIBK-UHFFFAOYSA-N 3-phenyl-1,3-oxazolidin-2-one Chemical compound O=C1OCCN1C1=CC=CC=C1 NCTCGHLIHJJIBK-UHFFFAOYSA-N 0.000 description 1
- LTENIVFVXMCOQI-UHFFFAOYSA-N 4,5-diphenyl-1,3-oxazolidin-2-one Chemical compound O1C(=O)NC(C=2C=CC=CC=2)C1C1=CC=CC=C1 LTENIVFVXMCOQI-UHFFFAOYSA-N 0.000 description 1
- CRHQYASHOICRND-UHFFFAOYSA-N 4-ethyl-1,3-oxazolidin-2-one Chemical compound CCC1COC(=O)N1 CRHQYASHOICRND-UHFFFAOYSA-N 0.000 description 1
- VAJFEOKPKHIPEN-UHFFFAOYSA-N 4-methyl-1,3-oxazolidin-2-one Chemical compound CC1COC(=O)N1 VAJFEOKPKHIPEN-UHFFFAOYSA-N 0.000 description 1
- QDMNNMIOWVJVLY-UHFFFAOYSA-N 4-phenyl-1,3-oxazolidin-2-one Chemical compound C1OC(=O)NC1C1=CC=CC=C1 QDMNNMIOWVJVLY-UHFFFAOYSA-N 0.000 description 1
- AZXNSLLITCXHBI-UHFFFAOYSA-N 4-propyl-1,3-oxazolidin-2-one Chemical compound CCCC1COC(=O)N1 AZXNSLLITCXHBI-UHFFFAOYSA-N 0.000 description 1
- LVWDOTMVYBUIMK-UHFFFAOYSA-N 5,5-diphenyl-1,3-oxazolidin-2-one Chemical compound O1C(=O)NCC1(C=1C=CC=CC=1)C1=CC=CC=C1 LVWDOTMVYBUIMK-UHFFFAOYSA-N 0.000 description 1
- ZSIFASRPEVGACI-UHFFFAOYSA-N 5-ethyl-1,3-oxazolidin-2-one Chemical compound CCC1CNC(=O)O1 ZSIFASRPEVGACI-UHFFFAOYSA-N 0.000 description 1
- HBRXQSHUXIJOKV-UHFFFAOYSA-N 5-methyl-1,3-oxazolidin-2-one Chemical compound CC1CNC(=O)O1 HBRXQSHUXIJOKV-UHFFFAOYSA-N 0.000 description 1
- QRDLRQBHRVUZJE-UHFFFAOYSA-N 5-propyl-1,3-oxazolidin-2-one Chemical compound CCCC1CNC(=O)O1 QRDLRQBHRVUZJE-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- PLZVEHJLHYMBBY-UHFFFAOYSA-N Tetradecylamine Chemical compound CCCCCCCCCCCCCCN PLZVEHJLHYMBBY-UHFFFAOYSA-N 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- RNNKOIIZECPRKX-UHFFFAOYSA-N bis(trifluoromethylsulfonyl)azanide;tetraoctylazanium Chemical compound FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F.CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC RNNKOIIZECPRKX-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000007805 chemical reaction reactant Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- YRTMEEURRDTMST-UHFFFAOYSA-N diazetidine Chemical compound C1CNN1 YRTMEEURRDTMST-UHFFFAOYSA-N 0.000 description 1
- 108010045501 diazocan Proteins 0.000 description 1
- KJGHYQZXEYTDSW-UHFFFAOYSA-N diazocane Chemical compound C1CCCNNCC1 KJGHYQZXEYTDSW-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- WBAZVXJXZJXWOR-UHFFFAOYSA-N ethyl azetidine-2-carboxylate Chemical compound CCOC(=O)C1CCN1 WBAZVXJXZJXWOR-UHFFFAOYSA-N 0.000 description 1
- LQCNSMGLNLPUIE-UHFFFAOYSA-N ethyl aziridine-2-carboxylate Chemical compound CCOC(=O)C1CN1 LQCNSMGLNLPUIE-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- CHNOQXRIMCFHKZ-UHFFFAOYSA-N methyl azetidine-2-carboxylate Chemical compound COC(=O)C1CCN1 CHNOQXRIMCFHKZ-UHFFFAOYSA-N 0.000 description 1
- UYCMTEJRGMIQLS-UHFFFAOYSA-N methyl aziridine-1-carboxylate Chemical compound COC(=O)N1CC1 UYCMTEJRGMIQLS-UHFFFAOYSA-N 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000002896 organic halogen compounds Chemical class 0.000 description 1
- YHYVSZZDQVQYOT-UHFFFAOYSA-N oxazepan-3-one Chemical compound O=C1CCCCON1 YHYVSZZDQVQYOT-UHFFFAOYSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 150000003235 pyrrolidines Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- QUERMGFVJPRMJL-UHFFFAOYSA-N tert-butyl azetidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC1 QUERMGFVJPRMJL-UHFFFAOYSA-N 0.000 description 1
- VBYPJHLRWKGNAI-UHFFFAOYSA-N tert-butyl aziridine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CC1 VBYPJHLRWKGNAI-UHFFFAOYSA-N 0.000 description 1
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 1
- 125000005497 tetraalkylphosphonium group Chemical group 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
- PPPHYGCRGMTZNA-UHFFFAOYSA-M trifluoromethyl sulfate Chemical compound [O-]S(=O)(=O)OC(F)(F)F PPPHYGCRGMTZNA-UHFFFAOYSA-M 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
Description
で表わされるオニウム塩系溶媒の中から選ばれた少なくとも1種を用いることを特徴とする環状ウレタンの製造方法を提供するものである。
で表わされるもの等が挙げられる。
で表わされるもの等が挙げられる。
オニウム塩系溶媒としては、アンモニウム塩系溶媒やホスホニウム塩系溶媒が好ましい。
アンモニウム塩系溶媒やホスホニウム塩系溶媒としては、一般式(1)
で表わされるものが好ましく挙げられる。
これらの溶媒は1種用いてもよいし、また、2種以上を組み合わせて用いてもよい。
これらの溶媒は超臨界二酸化炭素に溶解することがなく、VOCがほぼゼロに等しく、高温にも耐えうる。
しかも、これらの溶媒は、反応系によっては、粘度が非常に高いため、物質拡散定数が非常に小さいことから、しばしば反応を阻害することがあるものの、本発明方法では、共に用いられる二酸化炭素により、該溶媒の粘度が非常に低くなり、物質拡散定数が大きくなるため、反応が効果的に進行する。
また、二酸化炭素の圧力条件は、常圧、加圧、減圧の何れの条件下であってもよい。但し、原料の環状アミンの性質によっては二酸化炭素と反応し難い場合があり、その場合は適宜二酸化炭素の圧力を上昇させることで、収率を向上させることが可能である。特に二酸化炭素が亜臨界条件以上の圧力条件で、その収率が大きくなり始め、超臨界条件下である7.38MPa〜30MPaの範囲の圧力条件で収率は高くなる。但し、圧力を上げ過ぎると逆に収率が減少していくため、100MPaを越える圧力範囲とするのは好ましくない。本発明方法における二酸化炭素の圧力は、通常、常圧〜100MPaの範囲で適宜圧力条件を変えることで環状ウレタンが得られるが、好ましくは常圧〜50MPa、より好ましくは常圧〜30MPa、中でも特に7.38MPa〜30MPaの範囲とするのが望ましい。
本発明方法において、反応は超臨界二酸化炭素下とする、反応温度が31.1℃〜200℃、圧力が7.38MPa〜100MPaの範囲で行わせるのが好ましい。
また、原料の環状アミンとしては、アジリジン類、アゼチジン類、ピロリジン類、ピペリジン類を用いるのがよく、中でもアジリジン類、アゼチジン類を用いるのが、所期の効果をより良好に奏しうるので好ましい。
更に、反応にはオートクレーブ等の耐圧容器を用いるのが好ましく、環状ウレタンを良好な収率で得るには、ハロゲン、中でもヨウ素を触媒とするのがよい。
また、反応条件については、反応温度を0℃〜200℃、より好ましくは二酸化炭素を超臨界状態下とする、31.1℃〜200℃、圧力を常圧〜100MPa、より好ましくは二酸化炭素を超臨界状態下とする、7.38MPa〜100MPaの範囲とするのが好ましい。
反応媒体として、TOA−TFSIに代えて、下記の化8ないし化12のいずれかで表わされる各種のN‐メチル,N′‐アルキル‐イミダゾリウム塩系溶媒を用いた以外は実施例1と同様にして反応させ、分析した。その結果を表4に示す。
これより、反応媒体が、N′‐アルキル基のアルキル鎖長が4以上のイミダゾリウムテトラフルオロボレートの場合には、収率がほぼ100%という定量的値となることが分った。また、反応媒体が、Me−MI−CF3SO3の場合には収率が100%と定量値となることが分った。また、N′‐アルキル基のアルキル鎖長が2の場合でも、カウンターアニオンを、ヘキサフルオロホスフェート、トリフルオロメタンスルフェート、ブロモなど選択することにより、かなりの収率が得られることが分った。
Claims (8)
- ヨウ素触媒の存在下、環状アミンと二酸化炭素を反応させて環状ウレタンを製造する方法であって、反応媒体として、一般式(1)
で表わされるオニウム塩系溶媒の中から選ばれた少なくとも1種を用いることを特徴とする環状ウレタンの製造方法。 - 環状アミンが一般式(2)
で表わされ、環状ウレタンが一般式(3)
で表わされる請求項1記載の方法。 - 環状アミンが、アジリジン、アゼチジン、2‐アルキルアジリジン、2,3‐ジアルキルアジリジン、2‐アリールアジリジン、2,3‐ジアリールアジリジン、2‐アルキルアゼチジン、2,3‐ジアルキルアゼチジン、2‐アリールアゼチジン、2,3‐ジアリールアゼチジン、N‐アルキルアジリジン、N‐アリールアジリジン、N‐アラルキルアジリジン、N‐アルキルアゼチジン、N‐アリールアゼチジン及びN‐アラルキルアゼチジンの中から選ばれた少なくとも1種である請求項1又は2記載の方法。
- 環状アミンが、N‐(ヒドロキシアルキル)アジリジン、N‐(ヒドロキシアルキル)アゼチジン、N‐(アルコキシカルボニル)アジリジン、N‐(アルコキシカルボニル)アゼチジン、アジリジン‐2‐カルボン酸、アゼチジン‐2‐カルボン酸、アゼチジン‐2,3‐ジカルボン酸、アジリジン‐2‐カルボン酸アルキルエステル、アゼチジン‐2‐カルボン酸アルキルエステル、2‐(ニトロフェニル)アジリジン、2‐(ニトロフェニル)アゼチジン、N‐パラトルエンスルホニルアジリジン、N‐パラトルエンスルホニルアゼチジン及び2,3‐ジヒドロ‐1H‐イソインドールの中から選ばれた少なくとも1種である請求項1ないし3のいずれかに記載の方法。
- 反応温度を0℃〜200℃とする請求項1ないし4のいずれかに記載の方法。
- 圧力を常圧〜100MPaの範囲とする請求項1ないし5のいずれかに記載の方法。
- 反応を0℃〜200℃の温度、常圧〜100MPaの圧力の範囲で行う請求項1ないし6のいずれかに記載の方法。
- 反応温度が31.1℃〜200℃、圧力が7.38MPa〜100MPaの範囲の超臨界二酸化炭素中で行う請求項5ないし7のいずれかに記載の方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004013692A JP4324669B2 (ja) | 2004-01-21 | 2004-01-21 | 環状ウレタンの製造方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004013692A JP4324669B2 (ja) | 2004-01-21 | 2004-01-21 | 環状ウレタンの製造方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005206503A JP2005206503A (ja) | 2005-08-04 |
JP2005206503A5 JP2005206503A5 (ja) | 2007-05-17 |
JP4324669B2 true JP4324669B2 (ja) | 2009-09-02 |
Family
ID=34899681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004013692A Expired - Lifetime JP4324669B2 (ja) | 2004-01-21 | 2004-01-21 | 環状ウレタンの製造方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4324669B2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108554456A (zh) * | 2016-09-20 | 2018-09-21 | 苏州大学 | 一种稀土咪唑盐化合物作为催化剂的应用 |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2125750B1 (en) | 2007-02-26 | 2014-05-21 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
ATE554078T1 (de) | 2007-07-26 | 2012-05-15 | Vitae Pharmaceuticals Inc | Synthese von 11-beta-hydroxysteroid-dehydrogenase-1-hemmern |
EP2229368A1 (en) | 2007-12-11 | 2010-09-22 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
TW200934490A (en) | 2008-01-07 | 2009-08-16 | Vitae Pharmaceuticals Inc | Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1 |
EP2252601B1 (en) | 2008-01-24 | 2012-12-19 | Vitae Pharmaceuticals, Inc. | Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
CA2714532A1 (en) | 2008-02-11 | 2009-08-20 | Vitae Pharmaceuticals, Inc. | 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
JP5730021B2 (ja) | 2008-02-15 | 2015-06-03 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤としてのシクロアルキルラクタム誘導体 |
JP5538365B2 (ja) | 2008-05-01 | 2014-07-02 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤 |
US8138178B2 (en) | 2008-05-01 | 2012-03-20 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
JP5451752B2 (ja) | 2008-05-01 | 2014-03-26 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター |
CL2009001058A1 (es) | 2008-05-01 | 2010-09-10 | Vitae Pharmaceuticals Inc | Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras. |
NZ590495A (en) | 2008-07-25 | 2012-10-26 | Vitae Pharmaceuticals Inc | Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
TW201016691A (en) | 2008-07-25 | 2010-05-01 | Boehringer Ingelheim Int | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
CA2744946A1 (en) | 2009-02-04 | 2010-08-12 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
MA33216B1 (fr) | 2009-04-30 | 2012-04-02 | Boehringer Ingelheim Int | Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1 |
WO2011011123A1 (en) | 2009-06-11 | 2011-01-27 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
WO2011002910A1 (en) | 2009-07-01 | 2011-01-06 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
KR101102537B1 (ko) | 2009-07-31 | 2012-01-04 | 재단법인 포항산업과학연구원 | 디알킬카보네이트를 제조하는 방법 |
WO2011159760A1 (en) | 2010-06-16 | 2011-12-22 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
JP5813106B2 (ja) | 2010-06-25 | 2015-11-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 代謝障害の処置のための11−β−HSD1のインヒビターとしてのアザスピロヘキサノン |
WO2012059416A1 (en) | 2010-11-02 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
-
2004
- 2004-01-21 JP JP2004013692A patent/JP4324669B2/ja not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108554456A (zh) * | 2016-09-20 | 2018-09-21 | 苏州大学 | 一种稀土咪唑盐化合物作为催化剂的应用 |
Also Published As
Publication number | Publication date |
---|---|
JP2005206503A (ja) | 2005-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4324669B2 (ja) | 環状ウレタンの製造方法 | |
JP3873115B2 (ja) | 環状ウレタン製造方法 | |
EP1737850B1 (en) | A novel process for the preparation of linezolid and related compounds | |
CA2383298C (fr) | Nouveaux derives d'.alpha.-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
JP6507267B2 (ja) | 選択的ヒストンデアセチラーゼ阻害剤としてのヘテロ環状アルキル誘導体化合物及びこれを含有する薬剤学的組成物 | |
BR112018002304B1 (pt) | Compostos de derivado de 1,3,4-oxadiazol como inibidor de histona desacetilase 6 e a composição farmacêutica que compreende os mesmos | |
JP4803352B2 (ja) | アミノ酸−n−カルボキシ無水物の製造方法 | |
Jun et al. | Implementation of diverse synthetic and strategic approaches to biologically active sulfamides | |
KR20160101554A (ko) | N-[4-(1-아미노에틸)-페닐]-메탄술폰아미드 유도체의 카이랄 분할 방법 | |
CA2931606A1 (en) | Improved process for the preparation of pomalidomide and its purification | |
CN101220001A (zh) | 一种利奈唑酮的合成方法 | |
RU2499792C2 (ru) | Усовершенствованный способ получения ингибитора дипептидилпептидазы-iv и промежуточного соединения | |
JP2009114127A (ja) | アミノアセチルピロリジンカルボニトリル誘導体の製造方法 | |
JP2023516824A (ja) | ヒストン脱アセチル化酵素6阻害剤としての1,3,4-オキサジアゾール誘導体化合物、およびそれを含む医薬組成物 | |
Xu et al. | New mode of asymmetric induction for enantioselective radical N-heterobicyclization via kinetically stable chiral radical center | |
US9126903B2 (en) | Preparation method for solid powder of a carbamic acid derivative | |
FR2928150A1 (fr) | Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens | |
JP5938109B2 (ja) | リネゾリド中間体の調製方法 | |
TW201144289A (en) | Novel process for the preparation of piperazine compounds and hydrochloride salts thereof | |
US7777048B2 (en) | Processes for preparing biaryl ureas and analogs thereof | |
US8022227B2 (en) | Method of synthesizing 1H-indazole compounds | |
WO2012040853A1 (en) | Group 5 metal complexes useful for amine functionalization and synthetic process for manufacture thereof | |
CN1203597A (zh) | 5-萘-1-基-1,3-二噁烷衍生物,它们的制备和医疗用途 | |
JPH061776A (ja) | 置換ピラジンカルボニトリルの製造方法 | |
CN102558083B (zh) | N,n-双取代-3-氨基异噁唑-5-甲醇化合物的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050616 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070326 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20081210 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081218 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090216 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090507 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4324669 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
EXPY | Cancellation because of completion of term |